Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michiko Ohkusa"'
Autor:
Hiroshi Kusunoki, Michiko Ohkusa, Rie Iida, Ayumi Saito, Mikio Kawahara, Kazumi Ekawa, Nozomi Kato, Masaharu Motone, Hideo Shimizu
Publikováno v:
Clinical Case Reports, Vol 12, Iss 6, Pp n/a-n/a (2024)
Key Clinical Message Most Japanese patients naturally infected with COVID‐19 were infected after mRNA vaccination, and many maintained high antibody titers due to hybrid immunity. The significance of additional vaccination in hybrid‐immunized cas
Externí odkaz:
https://doaj.org/article/24018d8c960a47aba0418a82fcb03435
Autor:
Hiroshi Kusunoki, Michiko Ohkusa, Rie Iida, Ayumi Saito, Mikio Kawahara, Kazumi Ekawa, Nozomi Kato, Keita Yamasaki, Masaharu Motone, Hideo Shimizu
Publikováno v:
Vaccines, Vol 11, Iss 4, p 860 (2023)
Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers level and duration of elevated levels are considered important indicators for confirming the efficacy of coronavirus disease 2019 (COVID-19) vaccines. The objecti
Externí odkaz:
https://doaj.org/article/3df79a824941403ca062bdba305defc1
Autor:
Hiroshi Kusunoki, Michiko Ohkusa, Rie Iida, Ayumi Saito, Mikio Kawahara, Kazumi Ekawa, Nozomi Kato, Keita Yamasaki, Masaharu Motone, Hideo Shimizu
[Objective]Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers level and duration of elevated levels are considered important indicators for confirming the efficacy of coronavirus disease 2019 (COVID–19) vaccines. The objec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c2cf749fe408563d520ae099cf4d408
https://doi.org/10.1101/2023.02.04.23285414
https://doi.org/10.1101/2023.02.04.23285414
